Financhill
Back

Recursion Pharmaceuticals Vs. Insmed Industry Stock Comparison

Sell
33

RXRX
Recursion Pharmaceuticals

Last Price:
$5.23
Seasonality Move:
-11.7%
Buy
63

INSM
Insmed

Last Price:
$102.93
Seasonality Move:
0.06%
Sell
33
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $5.28. The Score for RXRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Insmed (INSM) is a Buy

Is Insmed a Buy, Sell or Hold?

  • The current Insmed [INSM] share price is $101.89. The Score for INSM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $5.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing slight selling pressure.

INSM Stock Price Chart

What is Insmed's stock price today?

  • The Insmed share price today is $101.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INSM is experiencing buying pressure, which is a positive indicator for future bullish movement.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.34 Buy
Relative Strength Index (14 RSI): 52.45 Buy
Chaikin Money Flow: -4084130 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.99 - 5.43) Buy
Bollinger Bands (100): (4.21 - 7.03) Sell

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.35 Buy
Relative Strength Index (14 RSI): 66.69 Buy
Chaikin Money Flow: 2938669 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.15 - 105.31) Buy
Bollinger Bands (100): (66.71 - 90.99) Buy

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.33 Sell
20-day SMA: 5.17 Buy
50-day SMA: 4.85 Buy
200-day SMA: 6.27 Sell
8-day EMA: 3.87 Buy
20-day EMA: 2.14 Buy
50-day EMA: 0.99 Buy
200-day EMA: 0.27 Buy

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.79 Buy
20-day SMA: 100.04 Buy
50-day SMA: 83.01 Buy
200-day SMA: 75.88 Buy
8-day EMA: 70.51 Buy
20-day EMA: 38.64 Buy
50-day EMA: 17.76 Buy
200-day EMA: 4.77 Buy

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.23 per share, an increase this year of $0.08 per share, and an increase next year of $0.31 per share.

Insmed Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $1.59 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Insmed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):